Literature DB >> 33392202

Control of T-Cell Activation and Signaling by Amino-Acid Catabolizing Enzymes.

Flavia Castellano1,2, Valérie Molinier-Frenkel1,2.   

Abstract

Amino acids are essential for protein synthesis, epigenetic modification through the methylation of histones, and the maintenance of a controlled balance of oxidoreduction via the production of glutathione and are precursors of certain neurotransmitters. T lymphocytes are particularly sensitive to fluctuations in amino acid levels. During evolution, the production of amino-acid catabolizing enzymes by mainly antigen-presenting cells has become a physiological mechanism to control T-cell activation and polarization. The action of these enzymes interferes with TCR and co-stimulation signaling, allowing tuning of the T-cell response. These capacities can be altered in certain pathological conditions, with relevant consequences for the development of disease.
Copyright © 2020 Castellano and Molinier-Frenkel.

Entities:  

Keywords:  TCR signaling; amino acid catabolizing enzymes; amino acid transporters; amino acids; immunoregulation

Year:  2020        PMID: 33392202      PMCID: PMC7773816          DOI: 10.3389/fcell.2020.613416

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN: 2296-634X


  3 in total

1.  What role for AHR activation in IL4I1-mediated immunosuppression ?

Authors:  Flavia Castellano; Armelle Prevost-Blondel; José L Cohen; Valérie Molinier-Frenkel
Journal:  Oncoimmunology       Date:  2021-05-12       Impact factor: 8.110

Review 2.  Targeting Metabolic Pathways of Myeloid Cells Improves Cancer Immunotherapy.

Authors:  Jianying Li; Chelsea Bolyard; Gang Xin; Zihai Li
Journal:  Front Cell Dev Biol       Date:  2021-12-20

3.  Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1-Dependent Myeloid Cells.

Authors:  E Kaitlynn Allen; Jeremy Chase Crawford; Lee-Ann Van de Velde; Taylor L Wilson; Clifford S Guy; Marion Russier; Leonie Zeitler; Armita Bahrami; David Finkelstein; Stephane Pelletier; Stacey Schultz-Cherry; Paul G Thomas; Peter J Murray
Journal:  Cancer Res       Date:  2021-07-23       Impact factor: 12.701

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.